Evidence map›Paper›PMID 34652486›Full record

ArticleZeitschrift fur Rheumatologie2022

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

U Kiltz, V Buschhorn-Milberger, K Albrecht, H-J Lakomek, H-M Lorenz, M Rudwaleit, M Schneider, H Schulze-Koops, M Aringer, M I Hasenbring and 11 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

U KiltzRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland. uta.kiltz@elisabethgruppe.de.
V Buschhorn-MilbergerRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.
K AlbrechtProgrammbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum (DRFZ), Berlin, Deutschland.
H-J LakomekJohannes-Wesling-Klinikum Minden, Universitätsklinik für Geriatrie, Minden, Deutschland.
H-M LorenzSektion Rheumatologie, Medizinische Klinik V, Universitätsklinikum Heidelberg, Universität Heidelberg, Heidelberg, Deutschland.
M RudwaleitUniversitätsklinik für Innere Medizin und Rheumatologie, Klinikum Bielefeld Rosenhöhe, Universität Bielefeld, Bielefeld, Deutschland.
M SchneiderPoliklinik, Funktionsbereich und Hiller Forschungszentrum für Rheumatologie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Deutschland.
H Schulze-KoopsSektion Rheumatologie und Klinische Immunologie, Medizinische Klinik und Poliklinik IV, LMU-Klinikum München, Ludwig-Maximilians-Universität München, München, Deutschland.
M AringerMedizinische Klinik und Poliklinik III, Rheumatologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Deutschland.
M I HasenbringAbteilung für Medizinische Psychologie und Medizinische Soziologie, Ruhr-Universität Bochum, Bochum, Deutschland.
P HerzerMedicover München MVZ, München, Deutschland.
U von HinüberPraxis für Rheumatologie und Osteologie, Hildesheim, Deutschland.
K KrügerRheumatologisches Praxiszentrum St. Bonifatius, München, Deutschland.
A LauterbachPhysiotherapieschule Friedrichsheim, Friedrichsheim, Deutschland.
B MangerMedizinische Klinik 3 Rheumatologie und Immunologie, Universitätsklinikum, Friedrich-Alexander-Universität Erlangen/Nürnberg, Erlangen, Deutschland.
R OltmanHochschule für Gesundheit Bochum, Bochum, Deutschland.
F SchuchRheumatologische Schwerpunktpraxis Erlangen, Erlangen, Deutschland.
R Schmale-GredeDeutsche Rheuma-Liga Bundesverband e. V., Bonn, Deutschland.
S Späthling-MestekemperRheumapraxis München, München, Deutschland.
S ZinkeRheumatologische Schwerpunktpraxis Zinke, Berlin, Deutschland.
J BraunRheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite a qualitatively and structurally good care of patients with rheumatoid arthritis (RA) in Germany, there are still potentially amendable deficits in the quality of care. For this reason, the German Society for Rheumatology (DGRh) has therefore decided to ask a group of experts including various stakeholders to develop quality standards (QS) for the care of patients with RA in order to improve the quality of care. The QS are used to determine and quantitatively measure the quality of care, subject to relevance and feasibility. The recently published NICE and ASAS standards and a systematic literature search were used as the basis for development. A total of 8 QS, now published for the first time, were approved with the intention to measure and further optimize the quality of care for patients with RA in Germany.

Indexed as

Arthritis, RheumatoidRheumatologyGermanyHumansCare gapsQuality of careQuality standardsRheumatoid arthritis

Identifiers

PMID34652486
PMCPMC9646547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.